Clinical trial results support adalimumab treatment for painful skin condition
The results of two phase 3 clinical trials that led to FDA approval of adalimumab for treatment of the chronic inflammatory skin disease hidradenitis suppurtiva (HS) are being published in the August 4 New England Journal ...
Aug 3, 2016